Cita APA

Magro, M., Mas-Lloret, V., Chappell, K., Vazquez-Alcaraz, M., Cano, O., Luque, D., . . . Palomo-Sanz, C. (2012). Neutralizing antibodies against the preactive form of respiratory syncytial virus fusion protein offer unique possibilities for clinical intervention.

Citación estilo Chicago

Magro, Margarita, Vicente Mas-Lloret, Keith Chappell, Monica Vazquez-Alcaraz, Olga Cano, Daniel Luque, Maria Carmen Terrón-Orellana, Jose Antonio Melero, y Concepcion Palomo-Sanz. Neutralizing Antibodies against the Preactive Form of Respiratory Syncytial Virus Fusion Protein Offer Unique Possibilities for Clinical Intervention. 2012.

Cita MLA

Magro, Margarita, et al. Neutralizing Antibodies against the Preactive Form of Respiratory Syncytial Virus Fusion Protein Offer Unique Possibilities for Clinical Intervention. 2012.